Special Issue "Micellar Drug Delivery"

Quicklinks

A special issue of Pharmaceutics (ISSN 1999-4923).

Deadline for manuscript submissions: closed (30 November 2012)

Special Issue Editor

Guest Editor
Prof. Dr. Vladimir P. Torchilin
Department of Pharmaceutical Sciences, School of Pharmacy, Bouve College of Health Sciences, Northeastern University, Mugar Building, Rm 312, 360 Huntington Avenue, Boston, MA 02129, USA
Website: http://www.northeastern.edu/bouve/directory/faculty.php?name=Vladimir%20P.%20Torchilin
E-Mail: v.torchilin@neu.edu
Phone: +617 373 3206
Fax: +617 373 7509
Interests: Drug carriers, Drug delivery sytems, Drug targeting, Liposomes, Micelles, Experimental cancer immunology, Imaging agents

Special Issue Information

Dear Colleagues,

Micells including polymeric micelles represent an important class of pharmaceutical carriers for poorly soluble diagnostic and therapeutic agents. Sable micelles with low CMC values maintain stability upon dilution and in biological fluids, demonstrate prolonged circulation times in vivo, and can be effectively loaded with various poorly soluble pharmaceuticals. Drug-loaded micelles demonstrate an increased accumulation in tumors via the enhanced permeability and retention (EPR) effect, and cytotoxicity of micellar formulations is usually markedly higher compared to free drugs. The potential of micellar drugs may be further improved by attaching targeting ligands, such as specific antibodies, to the micelle surface. By proper modification or synthetic chemistry, the micelles could be made stimuli-sensitive and capable of intracellular penetration. Many of these aspects of micellar drug delivery systems will be considered in this issue.

Prof. Dr. Vladimir P. Torchilin
Guest Editor

Keywords

  • pharmaceutical micelles
  • polymeric micelles
  • lipid-core micelles
  • drug delivery
  • drug targeting
  • poorly soluble drugs
  • drug solubilization

Published Papers (3 papers)

Pharmaceutics 2013, 5(2), 329-352; doi:10.3390/pharmaceutics5020329
Received: 22 January 2013; in revised form: 9 May 2013 / Accepted: 16 May 2013 / Published: 27 May 2013
Show/Hide Abstract | Cited by 3 | PDF Full-text (345 KB) | HTML Full-text | XML Full-text

Pharmaceutics 2013, 5(1), 201-219; doi:10.3390/pharmaceutics5010201
Received: 21 December 2012; in revised form: 28 February 2013 / Accepted: 13 March 2013 / Published: 22 March 2013
Show/Hide Abstract | Cited by 4 | PDF Full-text (269 KB) | HTML Full-text | XML Full-text

Pharmaceutics 2013, 5(1), 81-93; doi:10.3390/pharmaceutics5010081
Received: 13 November 2012; in revised form: 20 December 2012 / Accepted: 21 December 2012 / Published: 27 December 2012
Show/Hide Abstract | PDF Full-text (470 KB) | HTML Full-text | XML Full-text
abstract graphic

Last update: 4 March 2014

Pharmaceutics EISSN 1999-4923 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert